期刊文献+

氨苯砜脂质体凝胶的制备及其质量控制 被引量:1

Preparation and Quality Control of Dapsone Liposomal Gel
原文传递
导出
摘要 目的:制备氨苯砜脂质体凝胶,并建立其质量控制方法。方法:以氨苯砜为主药,采用薄膜-超声法制备其脂质体,研和法制备其脂质体凝胶;采用紫外分光光度法测定其中主药的含量。结果:所制制剂为乳黄色半固体凝胶,鉴别符合2005年版《中国药典》中的相关规定;氨苯砜检测浓度的线性范围为1.02~6.12μg·mL-1,平均回收率为100.31%(RSD=0.83%)。结论:本制剂制备工艺简单可行,质量稳定可控。 OBJECTIVE: To prepare dapsone liposomal gel and establish its quality control method. METHODS: With dapsone used as principal agent, the liposome was prepared by film-ultrasound method and the liposomal gel was prepared by mixing method. The content of dapsone was determined by UV spectrophotometry. RESULTS: The preparation was canary semisolid gel and its quality was up to the standard stated in Chinese Pharmacopeia (2005 Edition) . The linear range of dapsone was 1.02-6.12μg·mL^-1 and the average recovery rate was 100.31% (RSD = 0.83%).CONCLUSION : The preparation technique for the gel is feasible and the quality of the gel is stable and controllable.
出处 《中国药房》 CAS CSCD 北大核心 2009年第25期1969-1970,共2页 China Pharmacy
基金 济南青年科技明星计划(10109)
关键词 氨苯砜脂质体凝胶 紫外分光光度法 制备 质量控制 Dapsone liposomal gel Ultraviolet spectrophotometry Preparation Quality control
  • 相关文献

参考文献2

二级参考文献3

共引文献20

同被引文献20

  • 1陈亮,罗永强.氨苯砜固体分散体的制备与溶出度测定[J].医药导报,2006,25(4):333-334. 被引量:5
  • 2Hegarty AM,Ormond M,Sweeney M,et al.Dapsone efficacy and ad verse events in the management of mucous membrane pemphigoid[J].Eur J Dermatol,2010,20(2):223-224.
  • 3Kettle AJ,Winterbourn CC.Mechanism of inhibition of myeloperoxi dase by anti-inflammatory drugs[J].Biochem Pharmacol,1991,41 (10):1485-1492.
  • 4Diaz-Ruiz A,Zavala C,Montes S,et al.Antioxidnt,Antiinflammatory and Antiapoptotic Effects of Dapsone in a Model of Brain Ischemia/ Reperfusion in Rats[J].J Neurosci Res,2008,86(15):3410-3419.
  • 5Diaz-Ruiz A,Salgado-Ceballos H,Montes S,et al.Delayed administra tion of dapsone protects from tissue damage and improves recovery af ter spinal cord injury[J].J Neurosci Res,2011,89(3):373-380.
  • 6Abe M,Shimizu A,Yokoyama Y,et al.A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus[J].Clin Exp Dermatol,2008,33(6):759-763.
  • 7Schmidt E,Reimer S,Kruse N,et al.The IL-8 release from cultured human keratinocytes,mediated by antibodies to bullous pemphigoid autoantigen 180,is inhibited by dapsone[J].Clin Exp Immunol,2001,124(1)157-162.
  • 8Wozel VE.Innovative Use of Dapsone[J].Dermatol Clin,2010,28 (3):599-610.
  • 9Kannan G,Vasantha J,Rani NV,et al.Drug Usage Evaluation of Dap sone[J].Indian J Pharm Sci,2009,71 (4):456-460.
  • 10Draelos ZD,Carter E,Maloney JM,et al.Two randomized studies demonstrate the efficacy and safety of dapsone gel,5% for the treat ment of acne vulgaris[J].J Am Acad Dermatol,2007,56 (3):439.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部